MedPage Today (8/29, Gever) reports that, according to a study published online Aug. 28 in JAMA Psychiatry, “suspicions that psychiatric medications increase the mortality risk associated with mental illness were not borne out in a review of clinical trial data.” In the majority of cases, “death rates among more than 90,000 adult participants in trials of drugs for depression, schizophrenia, bipolar disorder, anxiety, and attention-deficit/hyperactivity disorder (AD/HD) were, for the most part, the same or lower in those assigned to active” medications versus placebo, with the sole exception of “heterocyclic antidepressants, a class of old-line agents such as imipramine and amitryptiline.”
Related Links:
— “Psych Drugs Don’t Raise Death Risk in Mental Illness, “John Gever, MedPage Today, August 29, 2013.